The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women.

Reproductive biomedicine online 20120601

Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: an experimental study in a rat model of benign prostatic hyperplasia.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20120601

Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.

Anticancer research 20120501

Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.

The Journal of urology 20120401

Luteinizing hormone-releasing hormone receptor antagonist may reduce postmenopausal flushing.

Menopause (New York, N.Y.) 20120201

Morphological and enzymatic changes caused by a long-term treatment of female rats with a low dose of gonadoliberin agonist and antagonist.

Medical science monitor : international medical journal of experimental and clinical research 20120101

The effects of cetrorelix and triptorelin on the viability and steroidogenesis of cultured human granulosa luteinized cells.

In vivo (Athens, Greece) 20120101

Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.

Taiwanese journal of obstetrics & gynecology 20111201

[Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].

Zhonghua fu chan ke za zhi 20111201

The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111101

Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111101

Evaluation of the effects of gonadotropin-releasing hormone antagonist (GnRH-ant) and agonist (GnRH-a) in the prevention of postoperative adhesion formation in a rat model with immunohistochemical analysis.

Fertility and sterility 20111101

Effects of cetrorelix, a GnRH-receptor antagonist, on gonadal axis in women with functional hypothalamic amenorrhea.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111001

Testosterone and oestradiol in concert protect seminiferous tubule maturation against inhibition by GnRH-antagonist.

International journal of andrology 20111001

A pilot study to assess the use of the gonadotrophin antagonist cetrorelix in preserving ovarian function during chemotherapy.

The Australian & New Zealand journal of obstetrics & gynaecology 20111001

[Use of GnRH antagonist for in vitro fertilization].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110906

Administration of a gonadotropin-releasing hormone antagonist to mares at different times during the luteal phase of the estrous cycle.

Animal reproduction science 20110901

Is anti-Müllerian hormone a marker of acute cyclophosphamide-induced ovarian follicular destruction in mice pretreated with cetrorelix?

Fertility and sterility 20110701

Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation.

Fertility and sterility 20110701

Hormone-induced delayed ovulation affects early embryonic development.

Fertility and sterility 20110601

Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.

Die Pharmazie 20110601

LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.

The Prostate 20110515

The heart: a novel gonadotrophin-releasing hormone target.

Journal of neuroendocrinology 20110501

Possible involvement of PACAP and PACAP type 1 receptor in GnRH-induced FSH β-subunit gene expression.

Regulatory peptides 20110411

Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix.

The Prostate 20110401

Effects of the gonadotropin-releasing hormone antagonist cetrorelix in the early postimplantation period on rat pregnancy.

European journal of obstetrics, gynecology, and reproductive biology 20110401

Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial.

Fertility and sterility 20110201

Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction-intrauterine insemination cycles: a randomized-controlled clinical trial.

Fertility and sterility 20110101

Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo.

Molecular cancer therapeutics 20110101

Milder is better? Advantages and disadvantages of 'mild' ovarian stimulation for human in vitro fertilization.

Reproductive biology and endocrinology : RB&E 20110101

Effect of GnRH antagonist therapy on the expression of MUC-1 and heparin binding growth factor expression in the endometrium of hyperstimulated rats.

Clinical and experimental obstetrics & gynecology 20110101

Cetrorelix suppresses the preovulatory LH surge and ovulation induced by ovulation-inducing factor (OIF) present in llama seminal plasma.

Reproductive biology and endocrinology : RB&E 20110101

Effect of serum progesterone level on the day of human chorionic gonadotropin injection on outcome following in vitro fertilization-embryo transfer in women using gonadotropin releasing hormone antagonists.

Clinical and experimental obstetrics & gynecology 20110101

Evidence that the main adverse effect of ganirelix on pregnancy and implantation rates is on the embryo rather than the endometrium.

Clinical and experimental obstetrics & gynecology 20110101

Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman.

BMJ case reports 20110101

Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix.

BJU international 20101101

Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors.

Fertility and sterility 20101101

Fluorescence spectroscopic determination of the critical aggregation concentration of the GnRH antagonists Cetrorelix, Teverelix and Ozarelix.

Journal of fluorescence 20101101

Gonadotropin releasing hormone antagonists suppress aromatase and anti-Müllerian hormone expression in human granulosa cells.

Fertility and sterility 20101001

Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an ex vivo model of human skin samples.

British journal of clinical pharmacology 20101001

Alarin stimulates food intake and gonadotrophin release in male rats.

British journal of pharmacology 20101001

Dose-ranging study of the luteinizing hormone-releasing hormone receptor antagonist cetrorelix pamoate in the treatment of patients with symptomatic benign prostatic hyperplasia.

Urology 20101001

Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.

Archives of gynecology and obstetrics 20100901

Progesterone administration route in gonadotropin-releasing hormone antagonist cycles.

Fertility and sterility 20100801

GnRH antagonist cetrorelix inhibits mitochondria-dependent apoptosis triggered by chemotherapy in granulosa cells of rats.

Gynecologic oncology 20100701

GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells.

Reproductive biomedicine online 20100701

Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study.

Fertility and sterility 20100601

Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.

The journal of obstetrics and gynaecology research 20100601

A circadian egg timer gates ovulation.

Current biology : CB 20100323

Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.

Fertility and sterility 20100301

Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist.

Reproductive biomedicine online 20100301

Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program.

Fertility and sterility 20100201

Plasma membrane expression of gonadotropin-releasing hormone receptors: regulation by peptide and nonpeptide antagonists.

Molecular endocrinology (Baltimore, Md.) 20100201

Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats.

Regulatory peptides 20100108

Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist.

Reproductive sciences (Thousand Oaks, Calif.) 20100101

Single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles: is the effect dependent on the type of GnRH analogue used for pituitary suppression?

Reproductive biomedicine online 20100101

Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle.

Gynecologic and obstetric investigation 20100101

Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide.

Reproductive biology and endocrinology : RB&E 20100101

A comparison of pregnancy rates following fresh and frozen embryo transfer according to the use of leuprolide acetate vs ganirelix vs cetrorelix.

Clinical and experimental obstetrics & gynecology 20100101

Effect of controlled ovarian hyperstimulation treatment on cardiac function.

The Journal of reproductive medicine 20100101

[Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].

La Tunisie medicale 20091201

Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion.

American journal of primatology 20091001

Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition.

International journal of oncology 20091001

GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.

Expert opinion on drug metabolism & toxicology 20091001

Luteinizing hormone-releasing hormone and postmenopausal flushing.

The New England journal of medicine 20090917

Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro.

Human reproduction (Oxford, England) 20090901

Neurotrophic effect of gonadotropin-releasing hormone on neurite extension and neuronal migration of embryonic gonadotropin-releasing hormone neurons in chick olfactory nerve bundle culture.

Journal of neuroscience research 20090801

Effects of the LHRH antagonist Cetrorelix on the brain function in mice.

Neuropeptides 20090601

Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40.

Fertility and sterility 20090501

Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.

Fertility and sterility 20090501

GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori.

Fertility and sterility 20090401

Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality.

Fertility and sterility 20090401

GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.

Fertility and sterility 20090401

What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?

Fertility and sterility 20090401

Predictors and implications of estradiol rise after gonadotropin-releasing hormone antagonist initiation during in vitro fertilization cycles.

The Journal of reproductive medicine 20090401

[Long GnRH agonist vs. GnRH antagonist protocol in randomized controlled trial in unselected patients--hormonal and cycle characteristics--pilot study].

Ceska gynekologie 20090401

Does premature luteinization or early surge of LH impair cycle outcome? Report of two successful outcomes.

Journal of assisted reproduction and genetics 20090301

In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.

Fertility and sterility 20090201

Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.

Fertility and sterility 20090201

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.

Fertility and sterility 20090201

Pretreatment with gonadotropin-releasing hormone (GnRH) antagonists to prevent the flare-up effect of long-acting GnRH agonists: results of a pilot study.

Fertility and sterility 20090201

Re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist Cetrorelix in patients with symptomatic benign prostatic hyperplasia. Eur Urol 2008;54:170-80.

European urology 20090201

The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.

Gynecologic oncology 20090201

Dihydrotestosterone and leptin regulate gonadotropin-releasing hormone (GnRH) expression and secretion in human GnRH-secreting neuroblasts.

The journal of sexual medicine 20090201

Frozen-thawed cleavage-stage embryo transfer cycles after previous GnRH agonist or antagonist stimulation.

Reproductive biomedicine online 20090101

Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090101

Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.

Neuroendocrinology 20090101

High doses of GnRH antagonists are efficient in the management of severe ovarian hyperstimulation syndrome.

Clinical and experimental obstetrics & gynecology 20090101

The effect of cetrorelix vs. ganirelix on pregnancy outcome using minimal gonadotropin stimulation in women with elevated day 3 serum follicle stimulating hormone levels.

Clinical and experimental obstetrics & gynecology 20090101

Gonadotropin releasing hormone (GnRH) enhances annexin A5 mRNA expression through mitogen activated protein kinase (MAPK) in LbetaT2 pituitary gonadotrope cells.

Endocrine journal 20081201

Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis.

The journal of obstetrics and gynaecology research 20081201

[Use of GnRh antagonist (Cetrorelix) in controlled ovarian hyperstimulation in women with polycystic ovary disease].

La Tunisie medicale 20081201

Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial.

Archives of gynecology and obstetrics 20081101

Modification of the in vitro release profile of Cetrorelix by complexation with biophilic partners.

Current drug delivery 20081001

Pyroglutamylated RFamide peptide 43 stimulates the hypothalamic-pituitary-gonadal axis via gonadotropin-releasing hormone in rats.

Endocrinology 20080901

'Empty follicle syndrome' after human error: pregnancy obtained after repeated oocyte retrieval in a gonadotropin-releasing hormone antagonist cycle.

Fertility and sterility 20080901

A randomised controlled trial comparing GnRH antagonist cetrorelix with GnRH agonist leuprorelin for endometrial thinning prior to transcervical resection of endometrium.

BJOG : an international journal of obstetrics and gynaecology 20080901

Cetrorelix suppression test in the diagnostic work-up of severe hyperandrogenism in adolescence.

Journal of pediatric endocrinology & metabolism : JPEM 20080901

Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis.

Fertility and sterility 20080801

Cumulative pregnancy rates after sequential treatment with modified natural cycle IVF followed by IVF with controlled ovarian stimulation.

Human reproduction (Oxford, England) 20080801

Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.

Human reproduction (Oxford, England) 20080801

Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis.

American journal of physiology. Endocrinology and metabolism 20080801

Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.

Fertility and sterility 20080701

Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.

Fertility and sterility 20080701

Editorial comment on: placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia.

European urology 20080701

Editorial comment on: placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia.

European urology 20080701

Editorial comment on: placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia.

European urology 20080701

Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia.

European urology 20080701

Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Müllerian hormone and inhibin-B.

Fertility and sterility 20080601

Effect of cetrorelix dose on premature LH surge during ovarian stimulation.

Reproductive biomedicine online 20080601

GnRH antagonists may affect endometrial receptivity.

Fertility and sterility 20080501

Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.

Fertility and sterility 20080401

The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome.

Journal of assisted reproduction and genetics 20080401

Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.

Fertility and sterility 20080301

Effect of a lower-dose cetrorelix acetate protocol on in-vitro fertilization outcome.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20080301

Effects of kisspeptin-10 on the electrophysiological manifestation of gonadotropin-releasing hormone pulse generator activity in the female rat.

Endocrinology 20080301

Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.

Taiwanese journal of obstetrics & gynecology 20080301

Involvement of amino acids flanking Glu7.32 of the gonadotropin-releasing hormone receptor in the selectivity of antagonists.

Molecules and cells 20080227

In vivo biodistribution of an androgen receptor avid PET imaging agent 7-alpha-fluoro-17 alpha-methyl-5-alpha-dihydrotestosterone ([(18)F]FMDHT) in rats pretreated with cetrorelix, a GnRH antagonist.

European journal of nuclear medicine and molecular imaging 20080201

Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines.

The Journal of endocrinology 20080201

Serum cetrorelix concentrations do not affect clinical pregnancy outcome in assisted reproduction.

Fertility and sterility 20080101

Molecular profiling of the human testis reveals stringent pathway-specific regulation of RNA expression following gonadotropin suppression and progestogen treatment.

Journal of andrology 20080101

Ovulation induction and pregnancy in a woman with premature menopause following gonadotropin suppression with the gonadotropin releasing hormone antagonist, cetrorelix--a case report.

Clinical and experimental obstetrics & gynecology 20080101

Use of GnRH antagonists in ovarian remnant syndrome experimentally induced in rats.

Clinical and experimental obstetrics & gynecology 20080101

Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration.

Fertility and sterility 20071201

Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist.

Human reproduction (Oxford, England) 20071101

Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study.

European journal of obstetrics, gynecology, and reproductive biology 20071001

GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles.

Fertility and sterility 20071001

Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.

American journal of physiology. Endocrinology and metabolism 20071001

The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.

The Prostate 20070901

Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Journal of assisted reproduction and genetics 20070801

Insights into male germ cell apoptosis due to depletion of gonadotropins caused by GnRH antagonists.

Apoptosis : an international journal on programmed cell death 20070601

Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070601

Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070501

Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal.

American journal of physiology. Endocrinology and metabolism 20070301

The effect of a short-term delay of puberty on trabecular bone mass and structure in female rats: a texture-based and histomorphometric analysis.

Bone 20070201

The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070201

Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist.

European journal of obstetrics, gynecology, and reproductive biology 20070101

GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial.

Human reproduction (Oxford, England) 20070101

Vesicular phospholipid gels: a technology platform.

Journal of liposome research 20070101

Impact of estradiol patterns in clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070101

Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070101

Preliminary report on the effect of a lower dose of gonadotropin-releasing hormone antagonist (cetrorelix) on ovarian hyperstimulation in lower-weight Asian women.

Taiwanese journal of obstetrics & gynecology 20061201

GnRH-antagonist mediated down-regulation of the estrous cycle in marmosets.

Journal of medical primatology 20061201

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis.

Reproductive biomedicine online 20061101

Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols.

Human reproduction (Oxford, England) 20061001

Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.

The Journal of steroid biochemistry and molecular biology 20061001

Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation.

Reproductive biomedicine online 20061001

Cetrorelix in the treatment of female infertility and endometriosis.

Expert opinion on pharmacotherapy 20061001

Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.

Human reproduction (Oxford, England) 20060901

Cetrorelix suppression test to assess the source of androgen overproduction in postmenopausal hirsutism.

European journal of endocrinology 20060901

Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients.

Human reproduction (Oxford, England) 20060801

Direct effect of progestogen on gene expression in the testis during gonadotropin withdrawal and early suppression of spermatogenesis.

The Journal of clinical endocrinology and metabolism 20060701

Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.

European journal of obstetrics, gynecology, and reproductive biology 20060601

Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study.

Human reproduction (Oxford, England) 20060601

Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20060601

Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20060601

Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles.

Journal of assisted reproduction and genetics 20060601

Is a lower dose of cetrorelix acetate effective for prevention of LH surge during controlled ovarian hyperstimulation?

Journal of assisted reproduction and genetics 20060601

Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix.

Fertility and sterility 20060501

Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.

Journal of assisted reproduction and genetics 20060501

IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.

Journal of endocrinological investigation 20060501

Dynamic changes in mitogen-activated protein kinase (MAPK) activities in the corpus luteum of the bonnet monkey (Macaca radiata) during development, induced luteolysis, and simulated early pregnancy: a role for p38 MAPK in the regulation of luteal function.

Endocrinology 20060401

[Endometriosis].

Nihon rinsho. Japanese journal of clinical medicine 20060401

[Clinical application of GnRH antagonist to uterine fibroid].

Nihon rinsho. Japanese journal of clinical medicine 20060401

[In vitro fertilization and embryo transfer].

Nihon rinsho. Japanese journal of clinical medicine 20060401

[Anti-tumor effects of GnRH analogs in gynecological cancers].

Nihon rinsho. Japanese journal of clinical medicine 20060401

Cetrorelix in women with poor ovarian response in previous assisted reproduction cycles.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20060401

Serum and follicular fluid levels of soluble Fas and soluble Fas ligand in IVF cycles.

European journal of obstetrics, gynecology, and reproductive biology 20060301

The use of gonadotropin-releasing hormone antagonist in ovarian stimulation.

Clinical obstetrics and gynecology 20060301

Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.

Fertility and sterility 20060301

Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol.

Fertility and sterility 20060301

Emerging drug therapies for benign prostatic hyperplasia.

Expert opinion on emerging drugs 20060301

GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system.

Oncology reports 20060201

Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist.

Fertility and sterility 20060201

Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20060201

Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles.

European journal of obstetrics, gynecology, and reproductive biology 20060101

Gi protein-mediated translocation of serine/threonine phosphatase to the plasma membrane and apoptosis of ovarian cancer cell in response to gonadotropin-releasing hormone antagonist cetrorelix.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20060101

Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol.

Reproductive biomedicine online 20051201

Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.

The Prostate 20051101

No effect of short-term testosterone manipulation on exercise substrate metabolism in men.

Journal of applied physiology (Bethesda, Md. : 1985) 20051101

Effect of cetrorelix acetate on apoptosis and apoptosis regulatory factors in cultured uterine leiomyoma cells.

Fertility and sterility 20051101

Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation.

Seminars in reproductive medicine 20051101

Ultrastructural and biochemical evidence for the presence of mature steroidogenic acute regulatory protein (StAR) in the cytoplasm of human luteal cells.

Molecular and cellular endocrinology 20051020

GnRH-I and GnRH-II have differential modulatory effects on human peripheral blood mononuclear cell proliferation and interleukin-2 receptor gamma-chain mRNA expression in healthy males.

Clinical and experimental immunology 20051001

Comparison of embryo implantation in Wistar rats that underwent ovarian stimulation using exogenous gonadotropins associated with cetrorelix acetate or leuprolide acetate.

Fertility and sterility 20051001

[GnRH antagonists and benign prostatic hyperplasia].

Annales d'urologie 20051001

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.

Human reproduction (Oxford, England) 20050901

Different effects of agonistic vs. antagonistic gnrh-analogues (triptorelin vs. cetrorelix) on bone modeling and remodeling in peripubertal female rats.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20050901

Gonadotrophin-releasing hormone-antagonist luteolysis during the preceding mid-luteal phase is a feasible protocol in ovarian hyperstimulation before in vitro fertilization.

Acta obstetricia et gynecologica Scandinavica 20050801

GnRH antagonist in IVF poor-responder patients: results of a randomized trial.

Reproductive biomedicine online 20050801

Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor.

Biochemical and biophysical research communications 20050729

Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies.

Fertility and sterility 20050701

Clinical suppression of precocious puberty with cetrorelix after failed treatment with GnRH agonist in a girl with gonadotrophin-independent precocious puberty.

Reproductive biomedicine online 20050701

A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy.

European journal of obstetrics, gynecology, and reproductive biology 20050601

Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration.

Fertility and sterility 20050601

Hormonal manipulations in the luteal phase to coordinate subsequent antral follicle growth during ovarian stimulation.

Reproductive biomedicine online 20050601

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.

Human reproduction (Oxford, England) 20050501

A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia.

Fertility and sterility 20050501

Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20050401

Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study.

Human reproduction (Oxford, England) 20050301

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial.

Human reproduction (Oxford, England) 20050301

Use of antagonists in ovarian stimulation protocols.

Reproductive biomedicine online 20050301

Gonadotropin-releasing hormone antagonist cetrorelix down-regulates proliferating cell nuclear antigen and epidermal growth factor expression and up-regulates apoptosis in association with enhanced poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human leiomyoma cells.

The Journal of clinical endocrinology and metabolism 20050201

Agonist 'flare-up' versus antagonist in the management of poor responders undergoing in vitro fertilization treatment.

Fertility and sterility 20050201

Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.

The Journal of reproductive medicine 20050201

GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects.

Endocrine journal 20050201

Use of GNRH antagonists in reproductive medicine.

Minerva ginecologica 20050201

Extrapituitary effects of GnRH antagonists in assisted reproduction: a review.

Reproductive biomedicine online 20050201

Modified natural cycle using GnRH antagonist can be an optional treatment in poor responders undergoing IVF.

Journal of assisted reproduction and genetics 20050201

Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.

British journal of cancer 20050131

Gonadotropin-releasing hormone antagonist (Cetrorelix) therapy fails to protect nonhuman primates (Macaca arctoides) from radiation-induced spermatogenic failure.

Journal of andrology 20050101

Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.

Hormone research 20050101

[Optimisation of possible success in an IVF program].

Zentralblatt fur Gynakologie 20041201

A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol.

Fertility and sterility 20041101

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction.

Reproductive biomedicine online 20041101

The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20041001

[The programming of IVF cycles with antagonists].

Journal de gynecologie, obstetrique et biologie de la reproduction 20041001

[Antagonist protocols: residual LH levels and the value of exogenous LH supplementation].

Journal de gynecologie, obstetrique et biologie de la reproduction 20041001

[Introduction of the antagonist: on a determined day or depending on follicular growth?].

Journal de gynecologie, obstetrique et biologie de la reproduction 20041001

Gonadotropin releasing hormone antagonists and cryopreservation outcome: a review.

Archives of gynecology and obstetrics 20040901

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study.

Human reproduction (Oxford, England) 20040901

Identification of novel genes regulated by LH in the primate corpus luteum: insight into their regulation during the late luteal phase.

Molecular human reproduction 20040901

Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.

Human reproduction (Oxford, England) 20040901

Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues.

European urology 20040901

GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol.

Journal of assisted reproduction and genetics 20040901

Evidence for different gonadotropin-releasing hormone response sites in rat ovarian and pituitary cells.

Biology of reproduction 20040801

Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles.

Fertility and sterility 20040801

Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor.

European journal of endocrinology 20040701

FSH time-concentration profiles before and after administration of 0.25 mg cetrorelix in the gnRH-antagonist multiple-dose protocol for ovarian hyperstimulation.

Journal of assisted reproduction and genetics 20040701

The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice.

Human reproduction (Oxford, England) 20040601

Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation.

Fertility and sterility 20040601

Hormonal regulation of human trophoblast differentiation: a possible role for 17beta-estradiol and GnRH.

Molecular and cellular endocrinology 20040415

Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age.

Fertility and sterility 20040401

Development and validation of a HPLC method for routine quantification of the decapeptide Cetrorelix in liposome dispersions.

Journal of pharmaceutical and biomedical analysis 20040310

Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary.

International journal of oncology 20040301

Triptorelin versus cetrorelix in intracytoplasmic sperm injection cycles in women with a single ovary.

European journal of obstetrics, gynecology, and reproductive biology 20040210

Gonadotropin-releasing hormone receptor gene expression during pubertal development of female rats.

Biology of reproduction 20040201

Adsorption of the decapeptide Cetrorelix depends both on the composition of dissolution medium and the type of solid surface.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201

[Comparison of GnRH agonists and antagonists in an ovular donation program].

Ginecologia y obstetricia de Mexico 20040201

Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration.

The Journal of biological chemistry 20040102

Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.

Pediatric research 20040101

Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?

Drugs 20040101

Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapy.

European journal of gynaecological oncology 20040101

Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells.

Anticancer research 20040101

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.

Fertility and sterility 20031201

Gonadal protection from radiation by GnRH antagonist or recombinant human FSH: a controlled trial in a male nonhuman primate (Macaca fascicularis).

The Journal of endocrinology 20031101

[Revisiting the clomifene-gonadotropin protocol in IVF with the use of a GnRH antagonist].

Gynecologie, obstetrique & fertilite 20031101

Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF.

Journal of assisted reproduction and genetics 20031101

GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors.

Molecules and cells 20031031

Regulatory effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the levels of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinases-1 in primary cultures of human extravillous cytotrophoblasts.

The Journal of clinical endocrinology and metabolism 20031001

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study.

Reproductive biomedicine online 20031001

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.

Gynecologic oncology 20030901

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment.

Reproductive biomedicine online 20030901

[Protocol of GNRH antagonist in poor responders in IVF-ET cycles].

Ginekologia polska 20030901

Prolactin inhibits annexin 5 expression and apoptosis in the corpus luteum of pseudopregnant rats: involvement of local gonadotropin-releasing hormone.

Endocrinology 20030801

Differential effects of gonadotropin-releasing hormone I and II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human decidual stromal cells in vitro.

The Journal of clinical endocrinology and metabolism 20030801

The use of gonadotropin-releasing hormone antagonist in a flexible protocol: a pilot study.

American journal of obstetrics and gynecology 20030801

Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells.

European journal of endocrinology 20030701

An overview of GnRH antagonists in infertility treatments. Introduction.

Fertility and sterility 20030701

The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase.

The Journal of clinical endocrinology and metabolism 20030701

The administration of the GnRH antagonist, cetrorelix, to ooctye donors simplifies oocyte donation.

Human reproduction (Oxford, England) 20030601

Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles.

Fertility and sterility 20030601

The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix.

Reproductive biomedicine online 20030601

Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences.

Reproductive biomedicine online 20030601

Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study.

Reproductive biomedicine online 20030601

No influence of body weight on pregnancy rate in patients treated with cetrorelix according to the single- and multiple-dose protocols.

Reproductive biomedicine online 20030601

Gonadotropin-releasing hormone receptor gene expression during pubertal development of male rats.

Biology of reproduction 20030501

Stimulation of luteinizing hormone secretion by N-methyl-D,L-aspartic acid in the adult male guinea-pig: incomplete blockade by gonadotropin-releasing hormone receptor antagonism.

Journal of neuroendocrinology 20030501

Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist.

Fertility and sterility 20030301

Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women.

Journal of clinical pharmacology 20030301

Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles.

Human reproduction (Oxford, England) 20030101

The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol.

Acta obstetricia et gynecologica Scandinavica 20030101

An evaluation of the multiple dose protocol of cetrorelix in single ovary women.

In vivo (Athens, Greece) 20030101

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.

Reproductive biology and endocrinology : RB&E 20030101

The effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human extravillous cytotrophoblasts in vitro.

The Journal of clinical endocrinology and metabolism 20021201

Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study.

Human reproduction (Oxford, England) 20021101

Effectiveness of an antagonist to gonadotrophin releasing hormone on the FSH and LH response to GnRH in perifused equine pituitary cells, and in seasonally acyclic mares.

Animal reproduction science 20020916

Regulation of microsomal P450, redox partner proteins, and steroidogenesis in the developing testes of the neonatal pig.

Endocrinology 20020901

Inhibition of recovery of spermatogenesis in irradiated rats by different androgens.

Endocrinology 20020901

Novel formulations of cetrorelix acetate in healthy men: pharmacodynamic effects and noncompartmental pharmacokinetics.

Journal of clinical pharmacology 20020901

[Use of GnRH antagonists (cetrorelix) in assisted reproduction: first report in Mexican literature].

Ginecologia y obstetricia de Mexico 20020901

Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

Human reproduction (Oxford, England) 20020801

Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix.

The Journal of clinical endocrinology and metabolism 20020801

An unusual steroid-producing ovarian tumour: case report.

Human reproduction (Oxford, England) 20020601

Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study.

European journal of obstetrics, gynecology, and reproductive biology 20020510

Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.

Fertility and sterility 20020401

[LH and GnRH antagonists].

Journal de gynecologie, obstetrique et biologie de la reproduction 20020401

Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle.

Fertility and sterility 20020301

Optimizing gonadotrophin-releasing hormone antagonist protocols.

Human fertility (Cambridge, England) 20020201

[GnRH antagonists].

Gynecologie, obstetrique & fertilite 20020101

Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF.

Archives of gynecology and obstetrics 20020101

New drugs 2002, part 1.

Nursing 20020101

Comparison of the effects of two GnRH antagonists on LH and FSH secretion, follicular growth and ovulation in the mare.

Reproduction, nutrition, development 20020101

[Reproductive health--new hormonal agents to treat infertility].

Akusherstvo i ginekologiia 20020101

Clomiphene-induced LH surges and cetrorelix.

Reproductive biomedicine online 20020101

Use of GnRH antagonists in the treatment of endometriosis.

Reproductive biomedicine online 20020101

The place of gonadotrophin-releasing hormone antagonists in reproductive medicine.

Reproductive biomedicine online 20020101

Structure-function studies of linear and cyclized peptide antagonists of the GnRH receptor.

Biochemical and biophysical research communications 20011207

Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).

Human reproduction (Oxford, England) 20011201

Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone.

Human reproduction (Oxford, England) 20011201

Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit.

Endocrinology 20011101

Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.

Human reproduction (Oxford, England) 20011101

LHRH antagonist decreases LH and progesterone secretion but does not alter length of estrous cycle in heifers.

Journal of animal science 20011101

Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis.

Archives of gynecology and obstetrics 20011101

[GnRH antagonists in IVF].

Journal de gynecologie, obstetrique et biologie de la reproduction 20011101

Use of gonadotrophin releasing hormone (GnRH) antagonist (cetrotide) during ovarian stimulation for in-vitro fertilization treatment: multiple doses and single dose.

The journal of obstetrics and gynaecology research 20011001

Histological effects of androgen deprivation on the adult chimpanzee epididymis.

Tissue & cell 20011001

Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.

Cancer letters 20010928

Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review.

Obstetrical & gynecological survey 20010901

The role of gonadotropin-releasing hormone antagonists in in vitro fertilization.

Seminars in reproductive medicine 20010901

Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders.

European journal of obstetrics, gynecology, and reproductive biology 20010801

Stimulation effect of galanin-like peptide (GALP) on luteinizing hormone-releasing hormone-mediated luteinizing hormone (LH) secretion in male rats.

Endocrinology 20010801

A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI.

Human reproduction (Oxford, England) 20010801

Applications for GnRH antagonists.

Trends in endocrinology and metabolism: TEM 20010801

Luteinizing hormone-releasing hormone antagonists in prostate cancer.

Urology 20010801

Low-temperature micronization of a peptide drug in fluid propellant: case study cetrorelix.

AAPS PharmSciTech 20010712

Testosterone inhibits spermatogonial differentiation in juvenile spermatogonial depletion mice.

Endocrinology 20010701

Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells.

European journal of endocrinology 20010601

Systemic delivery of cetrorelix to rats by a new aerosol delivery system.

Pharmaceutical research 20010601

Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.

The Journal of endocrinology 20010501

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial.

Human reproduction (Oxford, England) 20010501

Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.

Human reproduction (Oxford, England) 20010401

Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.

Fertility and sterility 20010201

Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20010201

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix.

Fertility and sterility 20010101

Stability of several LHRH antagonists against proteolytic enzymes and identification of degradation products by mass spectrometry.

Die Pharmazie 20010101

[GnRH antagonist].

Nihon rinsho. Japanese journal of clinical medicine 20010101

GnRH agonists and antagonists stimulate recovery of fertility in irradiated LBNF1 rats.

Journal of andrology 20010101

Gonadotrophin-releasing hormone antagonists for assisted conception.

The Cochrane database of systematic reviews 20010101

Residues within transmembrane helices 2 and 5 of the human gonadotropin-releasing hormone receptor contribute to agonist and antagonist binding.

Molecular endocrinology (Baltimore, Md.) 20000701

Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 19990101

Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.

Cancer research 19920501

Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.

The Prostate 19920101

Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters.

International journal of cancer 19910909